TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug

Prostate

Volumn 71, Issue 12, 2011, Pages 1332-1343

  Slabáková, Eva ^a,b   Pernicová, Zuzana ^a   Slavíčková, Eva ^a   Staršíchová, Andrea ^a,c   Kozubík, Alois ^a   Souček, Karel ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

benign hyperplasia; epithelial mesenchymal transition; miR 200 family; Slug; transforming growth factor 1

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; MICRORNA 200; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CARCINOGENICITY; CELL HYPERPLASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA INTERFERENCE;

BIOLOGICAL MARKERS; CELL LINE; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HOMEODOMAIN PROTEINS; HUMANS; KINETICS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PHENOTYPE; PROSTATIC HYPERPLASIA; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VIMENTIN;

EID: 79960705270     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21350     Document Type: Article

References (46)

1. Kalluri R, Weinberg RA,. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119 (6): 1420-1428.
2. Xu J, Lamouille S, Derynck R,. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19 (2): 156-172.
3. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A,. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci 2003; 116 (Pt 3): 499-511. (Pubitemid 36231290)
4. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R,. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24 (14): 2375-2385. (Pubitemid 40546696)
5. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F,. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7 (6): 1267-1278. (Pubitemid 32607360)
6. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA,. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117 (7): 927-939. (Pubitemid 38798858)
7. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA,. Mesenchyme forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 2007; 104 (24): 10069-10074. (Pubitemid 47175264)
8. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, Weinberg RA,. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA 2006; 103 (50): 18969-18974. (Pubitemid 350002812)
9. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, Cano A,. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem 2001; 276 (29): 27424-27431.
10. Lindley LE, Briegel KJ,. Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem Biophys Res Commun 2010; 399 (4): 659-664.
11. Kloosterman WP, Plasterk RH,. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11 (4): 441-450. (Pubitemid 44430905)
12. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ,. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10 (5): 593-601. (Pubitemid 351627379)
13. Bracken CP, Gregory PA, Khew-Goodall Y, Goodall GJ,. The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell Mol Life Sci 2009; 6 (10): 1682-1699.
14. Korpal M, Lee ES, Hu G, Kang Y,. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283 (22): 14910-14914.
15. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T,. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9 (6): 582-589. (Pubitemid 351772923)
16. Brabletz S, Brabletz T,. The, ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep 2010; 11 (9): 670-677.
17. Miettinen PJ, Ebner R, Lopez AR, Derynck R,. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J Cell Biol 1994; 127 (6 Pt 2): 2021-2036.
18. Miyazono K,. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85 (8): 314-323.
19. Wendt MK, Allington TM, Schiemann WP,. Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol 2009; 5 (8): 1145-1168.
20. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A,. Transforming growth factor-beta employs HMGA2 to elicit epithelial- mesenchymal transition. J Cell Biol 2006; 174 (2): 175-183. (Pubitemid 44079853)
21. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, Crystal RG, de Herreros AG, Moustakas A, Pettersson RF, Fuxe J,. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 2009; 11 (8): 943-950.
22. Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC,. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006; 17 (1-2): 19-27. (Pubitemid 43117513)
23. Starsichova A, Kubala L, Lincova E, Pernicova Z, Kozubik A, Soucek K,. Dynamic monitoring of cellular remodeling induced by the transforming growth factor-beta1. Biol Proced Online 2009; doi
24. Starsichova A, Lincova E, Pernicova Z, Kozubik A, Soucek K,. TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells. Cell Signal 2010; 22 (11): 1734-1744.
25. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR,. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001; 61 (22): 8135-8142. (Pubitemid 33091604)
26. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3 (6): 1101-1108. (Pubitemid 351818697)
27. Taylor MA, Parvani JG, Schiemann WP,. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 2010; 15 (2): 169-190.
28. Chu JH, Yu S, Hayward SW, Chan FL,. Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer. Prostate 2009; 69 (4): 428-442.
29. Ao M, Williams K, Bhowmick NA, Hayward SW,. Transforming growth factor-{beta} promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res 2006; 66 (16): 8007-8016. (Pubitemid 44299165)
30. van der Pluijm G,. Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone 2011; 48 (1): 37-43.
31. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA,. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133 (4): 704-715. (Pubitemid 351636299)
32. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH,. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS ONE 2010; 5 (8): e12445.
33. Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA,. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer 2005; 12 (3): 631-643. (Pubitemid 41482997)
34. Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S,. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J Biol Chem 2008; 283 (10): 6232-6240.
35. Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, Warner M, Gustafsson JA,. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci USA 2009; 106 (8): 2859-2863.
36. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P,. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 1995; 31 (1): 14-24.
37. Maeda M, Johnson KR, Wheelock MJ,. Cadherin switching: Essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 2005; 118 (Pt 5): 873-887. (Pubitemid 40484880)
38. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A,. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: The roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 2003; 163 (4): 847-857. (Pubitemid 37517891)
39. Kaida M, Cao F, Skumatz CM, Irving PE, Burke JM,. Time at confluence for human RPE cells: Effects on the adherens junction and in vitro wound closure. Invest Ophthalmol Vis Sci 2000; 41 (10): 3215-3224.
40. Hwang HW, Wentzel EA, Mendell JT,. Cell-cell contact globally activates microRNA biogenesis. Proc Natl Acad Sci USA 2009; 106 (17): 7016-7021.
41. Zhang C, Klymkowsky MW,. Unexpected functional redundancy between Twist and Slug (Snail2) and their feedback regulation of NF-kappaB via Nodal and Cerberus. Dev Biol 2009; 331 (2): 340-349.
42. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C,. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 2009; 15 (16): 5060-5072.
43. Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, Kurie JM,. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 2009; 23 (18): 2140-2151.
44. Sossey-Alaoui K, Bialkowska K, Plow EF,. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J Biol Chem 2009; 284 (48): 33019-33029.
45. Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, Allgayer H,. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in nonosmall cell lung cancer. Mol Cancer Res 2010; 8 (9): 1207-1216.
46. Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HRC, Sarkar FH,. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009; 27 (8): 1712-1721.